Global  

AstraZeneca's Coronavirus Vaccine Trial Can Continue In The US

Video Credit: Wochit Business - Duration: 00:32s - Published
AstraZeneca's Coronavirus Vaccine Trial Can Continue In The US

AstraZeneca's Coronavirus Vaccine Trial Can Continue In The US

AstraZeneca and the University of Oxford got the go-ahead to restart their US coronavirus vaccine trials.

The late-stage trial was stopped due to a possible adverse reaction in one of the participants.

On September 6 AstraZeneca reported a "suspected serious adverse reaction".

According to Business Insider, the reaction occurred in a UK-based participant.

The UK resumed clinical trials for AstraZeneca and the University of Oxford vaccines in September.


You Might Like

Related news from verified sources

Brazil Healthcare Regulator Says Patient in AstraZeneca Coronavirus Vaccine Trial Dies

The fatality is the latest setback for AZD1222, developed in coordination with the University of...
Motley Fool - Published Also reported by •NewsyNaturalNews.comUpworthy


Coronavirus vaccine trial subjects report extreme exhaustion, shortness of breath, day-long headaches and shaking so violently that one of them cracked a tooth

(Natural News) Get ready for the depopulation kill shots that cause severe neurological damage and...
NaturalNews.com - Published

AstraZeneca's coronavirus vaccine trial can continue in the US after being halted due to a participant having a 'serious adverse reaction'

AstraZeneca and the University of Oxford to resume late-stage trials for a COVID-19 vaccine in the...
Business Insider - Published


Related videos from verified sources

Questions over AstraZeneca's COVID-19 vaccine data [Video]

Questions over AstraZeneca's COVID-19 vaccine data

British drugmaker AstraZeneca is working with regulators to investigate a lower dosage of its vaccine that performed better than a full dosage, a spokesman for the company said on Thursday, after its..

Credit: Reuters - Politics     Duration: 01:29Published
AstraZeneca Admits COVID Breakthrough Came From Mistake [Video]

AstraZeneca Admits COVID Breakthrough Came From Mistake

AstraZeneca and the University of Oxford are facing criticism over their COVID-19 vaccine trial results. According to Business Insider the criticism comes after AstraZeneca admitted to a mistake in..

Credit: Wochit     Duration: 00:37Published
Dosing Mix-up Raises Questions About New COVID Vaccine [Video]

Dosing Mix-up Raises Questions About New COVID Vaccine

A manufacturing error is raising concerns about a promising COVID-19 vaccine being developed. The vaccine was developed by pharmaceutical company AstraZeneca and the University of Oxford. Less than a..

Credit: Wochit     Duration: 00:39Published